Blog13 March 2025 The Catch-22 of eConsent: The Missed Opportunity for Improved Clinical Trials It’s time to move beyond digital PDFs. Discover how real eConsent can transform trials, reduce dropout, and respect... Learn more
Blog27 February 2025 Build vs. Buy vs. Partner in Life Sciences: Making the Right Call How do you decide between building, buying, or partnering? Learn key decision factors and red flags to avoid... Learn more
Blog26 February 2025 Do CROs Need to Reinvent Themselves in 2025? A Deep Dive with Greg Licholai and Derk Arts High R&D costs aren’t due to a lack of innovation but inefficiencies in trials. Here’s how we can... Learn more
Blog16 January 2025 Clinical Trials Aren’t Just About Patients (and That’s Okay) This article explores the debate between patient-centricity and protocol-centricity in clinical trials, featuring insights from Derk Arts (Castor)... Learn more
Blog6 January 2025 Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection.... Learn more
Blog30 December 2024 What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,... Learn more
Blog20 December 2024 A New Perspective on Clinical Research: Accessibility and Innovation Joost Rigter’s inspiring journey highlights the importance of accessibility in clinical research. From AI-driven tools to simplified communication,... Learn more
Blog5 December 2024 Local Labs in the EDC: Streamlining Safety and Efficacy Insights Local labs are a vital part of clinical trials, offering fast, cost-effective insights into safety and efficacy. But... Learn more
Blog13 November 2024 Beyond Compliance: How Quality Culture Drives Clinical Trial Excellence Moving beyond compliance, quality culture drives clinical trial innovation through automated processes and measurable results. Learn more
Blog12 November 2024 eCOA Evolution: Have We Overcomplicated What Used to Work? A blueprint for engineering elegant eCOA solutions that make complex trials feel simple. Learn more
Blog30 September 2024 Waiver of Consent vs Waiver of Written Consent One is very common, the other is rarely granted. Learn the key differences between waiver of consent &... Learn more
Blog24 September 2024 Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality. Learn more
Blog11 September 2024 Understanding Phase 4 Clinical Trials: A Critical Component of Post-Marketing Insight to Drugs in the Real-World When it comes to Phase 4 clinical trials, Castor's cutting-edge Real-World Evidence (RWE) platform is your key to... Learn more
Blog9 August 2024 5 Key Takeaways from the FDA’s Real-World Evidence Guidance A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance... Learn more
Blog18 July 2024 Navigating the Evolving Regulatory and Data Landscape A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance... Learn more
Blog5 July 2024 Do We Still Need Patients in Tomorrow’s Trials? Modeling Placebo Effect and Beyond Discover the transformative role of AI in clinical trials, with expert insights from Derk Arts and MaryAnne Rizk... Learn more
Blog12 June 2024 eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data... Learn more
Event23 May 2024 DIA 2024 Meet us at Booth #2327 June 16 – 20, 2024 | San Diego Convention Center Meet the team at booth #2327 at DIA to discuss your RWE needs, get a demo and see... Learn more